President Donald Trump’s recently announced agreements with pharmaceutical companies are expected to have a limited effect on what most Americans pay for prescription drugs, according to health policy experts who say the scope and structure of the deals leave many patients unaffected. Since Sept. 30, the Trump administration has reached agreements with 14 drugmakers in exchange for relie

India has ushered in a new phase of insurance regulation with Parliament clearing the Sabka Bima Sabki Raksha (Amendment of Insurance Laws) Bill, 2025, a move that comes at a time when trust between insurers and policyholders is increasingly strained. For millions of Indians, insurance is ultimately judged not by policy documents or premium receipts but by the ease and fairness of claim settlement. Delays, repeated document requests, late-stage exclusions, and opaque rejections have long plag

The Union government has sought additional information from social media platform X regarding the steps taken to address obscene and sexually explicit content linked to its artificial intelligence tool, Grok, and the measures planned to prevent similar incidents in the future, according to sources familiar with the matter. The request follows a detailed response submitted by the platform, which officials have assessed as insufficient in addressing key regulatory concerns. Sources in